|
RSBN1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.70086167372574E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.81410458771825E-11 |
| Normal-vs-Stage2 |
1.68729999971973E-07 |
| Normal-vs-Stage3 |
1.6376011657826E-11 |
| Normal-vs-Stage4 |
1.24150023594893E-10 |
| Stage1-vs-Stage2 |
3.432000E-01 |
| Stage1-vs-Stage3 |
8.806000E-02 |
| Stage1-vs-Stage4 |
5.099900E-02 |
| Stage2-vs-Stage3 |
7.925800E-01 |
| Stage2-vs-Stage4 |
4.675000E-01 |
| Stage3-vs-Stage4 |
5.549000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.33337785257481E-13 |
| Normal-vs-AfricanAmerican |
3.324500E-03 |
| Normal-vs-Asian |
5.29179999819718E-08 |
| Caucasian-vs-AfricanAmerican |
1.457770E-01 |
| Caucasian-vs-Asian |
8.817400E-01 |
| AfricanAmerican-vs-Asian |
1.868550E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.91238169533881E-12 |
| Normal-vs-Female |
3.85458331919608E-12 |
| Male-vs-Female |
6.532800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.17160003920702E-09 |
| Normal-vs-Age(41-60Yrs) |
2.69310129752398E-11 |
| Normal-vs-Age(61-80Yrs) |
1.2712053631958E-11 |
| Normal-vs-Age(81-100Yrs) |
5.844500E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.972200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.225900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.900600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.068400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.881200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.718600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.324600E-03 |
| Classical-VS-Follicular |
9.059600E-03 |
| Classical-VS-Other |
7.088200E-01 |
| Classical-VS-Normal |
2.4383994823296E-10 |
| Tall-VS-Follicular |
4.487000E-01 |
| Tall-VS-Other |
5.204800E-01 |
| Tall-VS-Normal |
4.22469947913839E-10 |
| Follicular-VS-Other |
6.411400E-01 |
| Follicular-VS-Normal |
5.15659737132523E-11 |
| Other-VS-Normal |
1.482310E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.62099239481495E-12 |
| Normal-vs-N1 |
1.07149999983847E-09 |
| N0-vs-N1 |
4.486800E-01 |
|
|
